Sign In
Buy MGRM
$6.00
+0 (+0%)
At Close: Jan 06, 2026
Monogram Technologies Inc. (MGRM) Shareholder/Analyst Call Prepared Remarks Transcript
02:52pm, Tuesday, 30'th Sep 2025
Monogram Technologies Inc. (NASDAQ:MGRM ) Shareholder/Analyst Call September 30, 2025 1:00 PM EDT Company Participants Benjamin Sexson - Chairman of the Board, President & CEO Conference Call Particip
Zimmer Biomet Announces Second Quarter 2025 Financial Results
06:30am, Thursday, 07'th Aug 2025
Second quarter net sales of $2.077 billion increased 7.0% on a reported basis, 5.4% on a constant currency1 basis and 2.8% on an organic constant currency1 basis Second quarter diluted earnings per sh
Monogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
09:30am, Tuesday, 29'th Jul 2025
The Procedure Utilized Monogram's mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World's First Autonomous Saw-Based Robotic TKA Surgery on a Live Patie
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
MGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer Biomet
12:38pm, Monday, 14'th Jul 2025
MONSEY, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Monogram Technologies, Inc. (Nasdaq: MGRM) (“Monogram”)
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Monogram (NASDAQ: MGRM) for possible breaches of fiduciary duty and other violations of law in its transaction with Zimmer Biomet. Click her
MGRM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Monogram Technologies Inc. Is Fair to Shareholders
08:09am, Monday, 14'th Jul 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Monogram Technologies Inc. (NASDAQ: MGRM) to Zimmer Biomet Holdings, Inc. is fair to Mono
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earnings pe
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earning
Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock
08:30am, Tuesday, 08'th Jul 2025
AUSTIN, TEXAS / ACCESS Newswire / July 8, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, today announc
Monogram Technologies Inc. (MGRM) Q1 2025 Earnings Call Transcript
05:59pm, Wednesday, 14'th May 2025
Monogram Technologies Inc. (NASDAQ:MGRM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Noel Knape - Chief Financial Officer Ben Sexson
Monogram Technologies Reports First Quarter 2025 Financial Results
04:01pm, Wednesday, 14'th May 2025
Receives FDA Clearance for the mBôs™ TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business
Monogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern Time
08:31am, Tuesday, 06'th May 2025
AUSTIN, TX / ACCESS Newswire / May 6, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, will hold a confe
CORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in India
11:55am, Tuesday, 29'th Apr 2025
Monogram Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business Days C
Monogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in India
06:00am, Tuesday, 29'th Apr 2025
Patient Enrollment will Begin Shortly; First Live Patient Surgeries are Anticipated within 90 Business Days Critical Milestone Achieved for Multi-Center Clinical Trial in India with Strategic Partner
